fromSilicon Canals
2 months agoLeuven-based Augustine Therapeutics raises 77.7M to advance neuromuscular drug development - Silicon Canals
This significant financing is a testament to the innovative medicinal chemistry that Augustine was founded on, which acts via a unique mechanism of action.
Startup companies